<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations of lower extremity chronic venous disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations of lower extremity chronic venous disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations of lower extremity chronic venous disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Barbara M Mathes, MD, FACP, FAAD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lowell S Kabnick, MD, FACS, FACPh</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 15, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Chronic lower extremity venous disease is the most common vascular disorder [<a href="#rid1">1</a>]. Chronic venous disease refers to the presence of morphological (ie, venous dilation) or functional (eg, venous reflux) abnormalities of long duration and manifested by symptoms and/or signs indicating the need for further investigation or treatment [<a href="#rid2">2,3</a>].</p><p>Chronic venous disease encompasses the full spectrum of signs and symptoms associated with classes C0 to C6 of the Clinical-Etiology-Anatomy-Pathophysiology classification  (<a class="graphic graphic_table graphicRef52388" href="/d/graphic/52388.html" rel="external">table 1</a>), whereas classes C4 to C6 comprise "chronic venous insufficiency" or "advanced venous disease" [<a href="#rid4">4</a>]. </p><p>Initial clinical presentation is highly variable with the most common symptoms consisting of lower extremity heaviness, aching, swelling, itching, discomfort, and pain. Physical findings include abnormal venous dilation (ie, telangiectasias-corona phlebectatica, reticular veins, varicose veins), edema, inflammation, dermatitis, skin changes, and ulceration. Chronic venous insufficiency is associated with chronic disability, diminished quality of life, and high health care costs [<a href="#rid5">5-9</a>].</p><p>The clinical evaluation of chronic venous disease is reviewed here. The classification, diagnostic evaluation, and management of chronic venous disease are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders"</a> and  <a class="medical medical_review" href="/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">APPROACH TO THE PATIENT</span><span class="headingEndMark"> — </span>The diagnosis of chronic lower extremity venous disease is predominantly clinical. Initial evaluation consists of a thorough history and physical examination, with clinical classification of disease according to the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) criteria  (<a class="graphic graphic_table graphicRef52388" href="/d/graphic/52388.html" rel="external">table 1</a>) [<a href="#rid2">2</a>]. The CEAP classification is helpful in documenting venous disease both at initial presentation as well as in during follow-up examinations. The CEAP clinical classification is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders"</a> and <a class="local">'Clinical signs by CEAP category'</a> below.)</p><p>Because the presence of dilated veins is a common incidental finding on routine physical examination, many individuals are already aware that they have a vein problem. Up to one half of patients, even some with very large varicosities, have no specific symptoms [<a href="#rid10">10</a>]. Symptomatic patients may or may not correlate certain lower extremity symptoms with the presence of abnormal veins; alternatively, the patient may erroneously attribute symptoms that are more consistent with orthopedic or arterial vascular disease to their visible veins.</p><p>The major goal in the clinical evaluation of lower extremity chronic venous disease is a full clinical assessment of the lower extremities with correct interpretation of the patient's symptoms and correlation with physical signs [<a href="#rid3">3</a>]. Commonly, venous symptoms commonly occur later in the day rather than in the beginning and progress throughout the day. Sometimes venous symptoms can be confusing and overlap with other medical problems. Inconsistencies between symptoms and clinical signs may require additional diagnostic evaluation. (See  <a class="medical medical_review" href="/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Risk factors for venous disease</span><span class="headingEndMark"> — </span>The patient is often very interested in knowing why they have developed a vein problem. To help the patient better understand their disorder, the patient should be questioned specifically for risk factors known to contribute to the development of chronic venous disease. The most common risk factors include advancing age, family history of venous disease, increased body mass index, smoking, a history of lower extremity trauma, prior venous thrombosis, and, in women, pregnancy. A more complete review of risk factors is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease", section on 'Risk factors'</a>.)</p><p>Particular attention should be paid to identifying risk factors that can be modified (eg, obesity, lifestyle).</p><p>The patient who has no identifiable risk factors may have suffered a remote lower extremity trauma that they do not recall, or an undiagnosed deep vein thrombosis (DVT). Duplex ultrasound in these patients may identify valvular insufficiency, chronic vein wall thickening, or chronic thrombosis indicative of post-thrombotic syndrome [<a href="#rid11">11-13</a>]. (See  <a class="medical medical_review" href="/d/html/8200.html" rel="external">"Post-thrombotic (postphlebitic) syndrome"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Medical history</span><span class="headingEndMark"> — </span>A complete medical history should be obtained with particular attention to cardiovascular and other risk factors. </p><p>Patients with more severe clinical manifestations (ie, edema, inflammation, ulcer) are typically older and may have significant associated medical conditions (eg, peripheral artery disease [PAD], heart failure, diabetes, arthritis, obesity). </p><p>Chronic venous disease and arterial vascular disease have some common risk factors (eg, smoking, obesity) and pathophysiologic processes [<a href="#rid14">14</a>]. The presence of varicose veins was associated with arterial disease in two studies [<a href="#rid15">15,16</a>]. One of these, a cross-sectional study, documented a 36 percent increase in the risk of developing coronary artery disease for men with varicose veins [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Quality of life</span><span class="headingEndMark"> — </span>Health-related quality of life outcome measures are increasingly being considered in the evaluation of the outcomes of treatment for chronic venous disease [<a href="#rid17">17-20</a>]. Patients should be specifically questioned regarding the impact of symptoms on their daily activities, especially with respect to employment. The venous clinical severity score (VCSS) (<a class="calc calc_professional" href="/d/html/13453.html" rel="external">calculator 1</a>) and venous disability score (VDS) may aid with initial and follow-up assessment and, in the United States, are required by Medicare. (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'Measures of clinical severity'</a>.)</p><p>Individuals with varicose veins may have a lower perception of their general health compared to individuals without varicose veins, especially if clinical manifestations are more significant (eg, edema, skin changes) [<a href="#rid17">17</a>]. Quality of life measures improve with management of their superficial venous disease [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease", section on 'Management'</a>.)</p><p>Patients with severe skin changes or venous ulceration also have reductions in quality of life measures that are further reduced coincident with the need for chronic wound management [<a href="#rid18">18,19,22</a>]. Ulcer healing, however, may not always result in perceived improvements in quality of life [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/d/html/127144.html" rel="external">"Evaluation and management of chronic venous insufficiency including venous leg ulcer", section on 'Ulcer care'</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">SYMPTOMS</span><span class="headingEndMark"> — </span>The clinical presentation of symptoms varies widely. The onset of these symptoms relative to the appearance of visibly dilated veins, skin changes, edema, or ulceration should be ascertained and correlated with any positive risk factors. (See <a class="local">'Risk factors for venous disease'</a> above.)</p><p>The most common symptoms reported by patients with chronic venous disease are limb discomfort including leg heaviness or aching, throbbing or burning pain, itching, and limb swelling [<a href="#rid24">24</a>]. Pain and limb discomfort were reported as a significant symptom for each of the six Clinical-Etiology-Anatomy-Pathophysiology (CEAP) clinical categories in at least 50 percent of individuals surveyed in one large cross-sectional study [<a href="#rid10">10</a>]. Pain may be generalized (ie, aching, burning) or localized to specific veins, areas of skin discoloration (hemosiderin deposition; alone or coupled with inflammation), or areas of lipodermatosclerosis or ulceration. When pain accompanies more severe clinical manifestations, ambulation may become difficult or even impossible.</p><p>Pain associated with venous disease is typically worse when standing, or when seated with the feet dependent for prolonged periods of time, and improves with limb elevation and walking [<a href="#rid25">25</a>]. These features distinguish chronic venous disease from typical symptoms associated with lower extremity occlusive peripheral artery disease. Patients with mild-to-moderate lower extremity PAD (ie, claudication) complain of pain with walking that is relieved by rest while those with more severe PAD may complain of more pain when the limb is elevated. (See  <a class="medical medical_review" href="/d/html/8208.html" rel="external">"Clinical features and diagnosis of lower extremity peripheral artery disease"</a>.)</p><p>The pain associated with venous disease is typically directly associated with the affected veins, skin changes, or ulceration; it does not radiate as with radiculopathies and is not exacerbated by joint movement as in arthritis. (See  <a class="medical medical_review" href="/d/html/5262.html" rel="external">"Acute lumbosacral radiculopathy: Etiology, clinical features, and diagnosis"</a>.)</p><p>With venous disease, extremity swelling is quite common, whether related to venous insufficiency or obstruction, Extremity swelling is reported by 25 to 75 percent of patients and correlates with increasing clinical severity (ie, increasing CEAP category). With isolated superficial venous insufficiency, ankle swelling is common, whereas ankle, calf, and/or thigh is more common with deep venous insufficiency and/or deep venous obstruction. Swelling is generally worse with prolonged standing and improves with leg elevation and walking. In females, exacerbation of symptoms may occur with the menses or pregnancy, due to increased fluid volume and/or higher circulating levels of estrogen.</p><p>Other symptoms include limb aching or generalized fatigue, skin discoloration or redness, muscle cramping, restless legs, numbness, tingling, or itching. Numbness and tingling due to chronic venous disease can become chronic and may be difficult to distinguish from other causes of peripheral neuropathy that affect the lower extremity [<a href="#rid26">26-28</a>]. (See  <a class="medical medical_review" href="/d/html/5096.html" rel="external">"Approach to the patient with sensory loss", section on 'Distal sensory polyneuropathy'</a>.)</p><p>Some patients with chronic venous disease may seek medical attention for the first time due to chronic ulcers, or bleeding that can be spontaneous (varicose vein hemorrhage) or related to a wound. The prevalence of nonhealing venous ulcers for more than a year has been reported in 55 to 60 percent of patients with inadequately treated chronic venous disease [<a href="#rid29">29-32</a>]. </p><p>Patients should be asked about the number and location of prior ulcerations, as well as the nature of any treatments used to aid in wound care. A history of a previous venous ulcer is the strongest predictor of recurrent ulceration [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H7"><span class="h1">PHYSICAL ASSESSMENT</span><span class="headingEndMark"> — </span>The patient should undergo a complete physical examination with a detailed lower extremity examination that includes assessment of clinical signs of venous disease (see <a class="local">'Clinical signs by CEAP category'</a> below), pulse examination, and neurologic assessment [<a href="#rid3">3,33</a>]. The goal of physical assessment is to correlate the patient's symptoms with the clinical signs of venous disease, and ultimately, with diagnostic vascular laboratory findings (eg, duplex ultrasound). (See  <a class="medical medical_review" href="/d/html/8196.html" rel="external">"Diagnostic evaluation of lower extremity chronic venous disease"</a>.)</p><p>It is important to keep in mind that a subset of patients with chronic venous disease may have typical symptoms but no visible clinical signs. Clinicians may occasionally report their patients having tenderness to palpation; however, this finding in not typical in chronic venous disease (in the absence of active phlebitis). (See  <a class="medical medical_review" href="/d/html/8199.html" rel="external">"Superficial vein thrombosis and phlebitis of the lower extremity veins"</a>.)</p><p>The femoral and pedal pulses (ie, dorsalis pedis and posterior tibial pulses) are usually palpable. For those in whom the clinician is unable to palpate the pedal pulses, a handheld Doppler ultrasound may be necessary to assess arterial flow. If there are any indications of arterial ischemia (ie, cool extremity, pulselessness, forefoot or digital ulceration), further noninvasive arterial evaluation should be undertaken.</p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL SIGNS BY CEAP CATEGORY</span><span class="headingEndMark"> — </span>The Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification is a method to categorize chronic venous disorders to serve as a basis for standardized reporting. The visible signs of chronic venous disorders are categorized as C0 to C6 depending on appearance  (<a class="graphic graphic_table graphicRef52388" href="/d/graphic/52388.html" rel="external">table 1</a>) [<a href="#rid34">34</a>]. CEAP is a classification system and should not be used as a measure of the clinical severity of venous disease. (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'CEAP classification'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">No clinical signs (C0)</span><span class="headingEndMark"> — </span>Approximately 20 percent of patients with clinical symptoms consistent with a chronic venous disorder have no visible clinical signs [<a href="#rid10">10</a>]. Duplex examination identifies functional disease (ie, venous reflux) in approximately 20 percent of these patients. (See  <a class="medical medical_review" href="/d/html/8181.html" rel="external">"Overview of lower extremity chronic venous disease", section on 'Management'</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Telangiectasia/reticular veins (C1)</span><span class="headingEndMark"> — </span>The most frequently encountered manifestation of venous disease is mild venous dilation. </p><p class="bulletIndent1"><span class="glyph">●</span>Telangiectasias are a confluence of dilated intradermal venules/capillaries less than 1 millimeter in diameter  (<a class="graphic graphic_picture graphicRef62119" href="/d/graphic/62119.html" rel="external">picture 1</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reticular veins are dilated, bluish subdermal veins, 1 to 3 millimeters in diameter, and are usually tortuous. </p><p></p><p class="headingAnchor" id="H11"><span class="h2">Varicose veins (C2)</span><span class="headingEndMark"> — </span>Varicose veins are subcutaneous dilated, tortuous veins greater than three millimeters in diameter  (<a class="graphic graphic_picture graphicRef68551" href="/d/graphic/68551.html" rel="external">picture 2</a>). They may involve the saphenous veins, saphenous tributaries, or nonsaphenous superficial leg veins  (<a class="graphic graphic_figure graphicRef55019 graphicRef52340" href="/d/graphic/55019.html" rel="external">figure 1A-B</a>). (See  <a class="medical medical_review" href="/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'Anatomy (The "A" component of CEAP)'</a>.)</p><p>The appearance of visible varicose veins is often the most common concern. However, it is important to note that varicose veins are often associated with superficial axial venous reflux (eg, great saphenous vein, small saphenous vein). (See  <a class="medical medical_review" href="/d/html/121344.html" rel="external">"Approach to treating symptomatic superficial venous insufficiency"</a>.)</p><p class="headingAnchor" id="H884134384"><span class="h2">Edema (C3)</span><span class="headingEndMark"> — </span>Longstanding venous disease associated with venous reflux is characterized by the development of dependent ankle edema  (<a class="graphic graphic_picture graphicRef70438" href="/d/graphic/70438.html" rel="external">picture 3</a>), which may progress over time to include the calf region. In the early stages of chronic venous insufficiency, edema may be present only at the end of the day; however, with time it can become persistent throughout the day.</p><p>The presence of edema is not a specific finding. It occurs when the hydrostatic pressure gradient is substantially increased (eg, heart failure, renal failure, or locally with venous thrombosis or insufficiency), the oncotic pressure gradient is substantially reduced (marked hypoalbuminemia), vascular (capillary) permeability is increased, or lymphatic flow is obstructed  (<a class="graphic graphic_table graphicRef53550" href="/d/graphic/53550.html" rel="external">table 2</a>). Other etiologies may also lead to lower extremity edema. (See  <a class="medical medical_review" href="/d/html/2309.html" rel="external">"Pathophysiology and etiology of edema in adults"</a> and  <a class="medical medical_review" href="/d/html/755.html" rel="external">"Clinical features and diagnosis of peripheral lymphedema"</a> and  <a class="medical medical_review" href="/d/html/14924.html" rel="external">"Popliteal (Baker's) cyst"</a>.)</p><p>The following clues point to venous insufficiency as the cause of lower extremity edema:</p><p class="bulletIndent1"><span class="glyph">●</span>The edema is limited to the lower extremities and is often unilateral (particularly early) and is accompanied by venous abnormalities (telangiectasias, reticular veins, varicose veins), hyperpigmentation, or other signs of venous disease. By contrast, the edema in generalized edematous states is usually bilateral and is often not limited to the legs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The edema typically subsides with recumbency. While many other edematous states also improve in this setting, this finding distinguishes venous insufficiency from chronic lymphatic obstruction, which is often unilateral and may not subside with recumbency. (See  <a class="medical medical_review" href="/d/html/755.html" rel="external">"Clinical features and diagnosis of peripheral lymphedema"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The central venous pressure is normal, a finding that excludes heart failure as a cause for the edema. This distinction is more difficult when both heart failure and venous disease are present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who have been given diuretics will have a poor response and can develop signs of hypoperfusion.</p><p></p><p class="headingAnchor" id="H22065940"><span class="h2">Chronic venous insufficiency</span><span class="headingEndMark"> — </span>Chronic severe edema (see <a class="local">'Edema (C3)'</a> above), skin changes (pigmentation, dermatitis, lipodermatosclerosis), and venous ulceration are signs of advanced venous disease (ie, chronic venous insufficiency) [<a href="#rid35">35</a>], which is associated with superficial and/or deep venous reflux and/or obstruction [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/d/html/127144.html" rel="external">"Evaluation and management of chronic venous insufficiency including venous leg ulcer"</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Skin pigmentation/dermatitis (C4a)</span><span class="headingEndMark"> — </span>Pigmentation changes are initially most prominent at the medial ankle but subsequently may encroach upon the foot and lower leg  (<a class="graphic graphic_picture graphicRef56758" href="/d/graphic/56758.html" rel="external">picture 4</a>). Brown and blue-grey hyperpigmentation on the anterior lower leg is a common finding. The pigmentation is due to hemosiderin deposition, which derives from the breakdown of red blood cells that have extravasated through damaged capillaries into the dermis because of venous hypertension.</p><p>Individuals with functional venous disease due to venous reflux are prone to develop stasis dermatitis, which is a common and possibly early dermatologic sign of chronic venous insufficiency. Stasis dermatitis is an inflammatory process that presents as an eczematous rash characterized by itching, erythema, scaling, weeping, erosions, and crusting  (<a class="graphic graphic_picture graphicRef58465" href="/d/graphic/58465.html" rel="external">picture 5</a>).</p><p>The pruritus associated with the dry, scaly skin can be difficult to relieve; excoriations are often present secondary to scratching and can be a source of skin infection. Rashes mimicking the dermatitis on the legs can appear as eczematous patches on other body sites or can present as a generalized body rash, an auto eczematous or "id" reaction  (<a class="graphic graphic_picture graphicRef51553" href="/d/graphic/51553.html" rel="external">picture 6</a>).</p><p>Atrophie blanche manifests as atrophic, hypopigmented patches with focal red punctate dots or telangiectasias, surrounded by hyperpigmentation. These are most often seen on the medial distal leg near the malleolus, or can occur within lipodermatosclerotic skin, where they correspond to points of avascular fibrosis  (<a class="graphic graphic_picture graphicRef67105" href="/d/graphic/67105.html" rel="external">picture 7</a>). These areas do not represent healed venous ulcers, but they are vulnerable to future ulceration because of poor perfusion. (See  <a class="medical medical_review" href="/d/html/4684.html" rel="external">"Livedoid vasculopathy"</a> and <a class="local">'Venous ulceration (C5, C6, C6r)'</a> below.)</p><p class="headingAnchor" id="H14"><span class="h3">Lipodermatosclerosis (C4b)</span><span class="headingEndMark"> — </span>Chronic venous insufficiency of sufficient severity (eg, following severe cases of deep venous thrombosis or that associated with lymphatic compromise) may lead to the development of lipodermatosclerosis, a fibrosing panniculitis of the subcutaneous tissue. This disorder is characterized by a firm area of induration, which is initially located at the medial ankle  (<a class="graphic graphic_picture graphicRef65447" href="/d/graphic/65447.html" rel="external">picture 8</a>) and in the acute phase can be exquisitely tender to touch [<a href="#rid37">37</a>]. As the process progresses, the entire leg can become circumferentially involved with extension up to the mid leg in more advanced cases  (<a class="graphic graphic_picture graphicRef76901" href="/d/graphic/76901.html" rel="external">picture 9</a>).</p><p>The skin overlying the panniculitis is typically heavily pigmented and bound down to the subcutaneous tissues. The fibrosis may be so extensive and constrictive as to girdle and strangle the lower leg, further impeding lymphatic and venous flow. Brawny edema above the fibrotic area and on the foot below is seen in advanced cased of lipodermatosclerosis. The limb now resembles an inverted champagne bottle; the bulbous cork represents the lymphedematous foot, the fibrosed area the neck of the bottle, and edematous leg the body of the bottle  (<a class="graphic graphic_picture graphicRef73283" href="/d/graphic/73283.html" rel="external">picture 10</a>).</p><p>Characteristic histologic findings are almost exclusively in the subcutaneous tissue and include adipose changes such as micropseudocyst and macropseudocyst formation, necrotic adipocytes, lipomembranous change, and lipogranulomas with xanthomatous macrophages. In a pathologic study of 25 cases, the lesions were largely devoid of dermal, septal, or lobular neutrophilic or lymphocytic inflammation [<a href="#rid38">38</a>]. Medium vessel calcification was seen in 13 cases. The accumulation of basophilic elastic fibers located deep in the septa was present in all the cases. </p><p>Patients with lipodermatosclerosis are particularly prone to repeated bouts of cellulitis, usually caused by Staphylococcal or Streptococcal organisms  (<a class="graphic graphic_picture graphicRef77986" href="/d/graphic/77986.html" rel="external">picture 11</a>). (See  <a class="medical medical_review" href="/d/html/110529.html" rel="external">"Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H3931215591"><span class="h3">Corona phlebectatica (C4c)</span><span class="headingEndMark"> — </span>The presence of corona phlebectatica, which is a crown of numerous small intradermal veins on the medial or lateral aspects of the ankle and foot  (<a class="graphic graphic_picture graphicRef86549" href="/d/graphic/86549.html" rel="external">picture 12</a>) [<a href="#rid34">34</a>], is often a clinical indicator of venous hypertension secondary to saphenous or perforator venous insufficiency [<a href="#rid34">34</a>]. One series review reported that patients with the physical examination finding of corona phlebectatica had a fourfold increased risk of an incompetent superficial axial vein or an incompetent perforating vein [<a href="#rid39">39</a>]. There was no correlation between deep venous insufficiency and corona phlebectatica in this study. </p><p class="headingAnchor" id="H15"><span class="h3">Venous ulceration (C5, C6, C6r)</span><span class="headingEndMark"> — </span>Chronic venous disease is a common cause of lower extremity ulcers [<a href="#rid29">29-32,40</a>]. Patients commonly have superficial reflux, deep venous reflux/obstruction, or perforator reflux, alone or in combination. Risk factors associated with venous ulcer formation include older age, low physical activity, arterial hypertension, lipodermatosclerosis, obesity, and family history of venous ulceration [<a href="#rid41">41-43</a>].</p><p>Venous ulcers (C5: healed; C6: active; C6r: recurrent) are usually located low on the medial ankle over a perforating vein or sometimes near on the lateral malleolus, or along the course of the great or small saphenous veins  (<a class="graphic graphic_figure graphicRef55019 graphicRef52340" href="/d/graphic/55019.html" rel="external">figure 1A-B</a>); they can occur more proximally on the leg if precipitated by trauma, but never in the forefoot or above the level of the knee. The ulcers may be multiple or single and are exquisitely tender when infected, shallow, exudative, and have a granulation base  (<a class="graphic graphic_picture graphicRef71020" href="/d/graphic/71020.html" rel="external">picture 13</a>). The ulcer borders are usually irregular but not undermined. They can extend circumferentially around the leg if left untreated [<a href="#rid4">4</a>].</p><p>These characteristic findings often allow distinction between venous ulcers and the following types of ulcers that also appear on the lower extremities  (<a class="graphic graphic_table graphicRef63577" href="/d/graphic/63577.html" rel="external">table 3</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Arterial ulcers are typically painful and punched out or stellate in appearance. The surrounding skin is red and taut. Some arterial ulcers are pale; others may have a black or yellow eschar. On the leg, they are more often associated with trauma and commonly occur on the foot over pressure points. In addition, the leg and/or foot may display other signs of arterial insufficiency, including thin atrophic and hairless skin, poor or absent pedal pulses, diminished capillary refill, or hypertrophic deformed nails. (See  <a class="medical medical_review" href="/d/html/8208.html" rel="external">"Clinical features and diagnosis of lower extremity peripheral artery disease", section on 'Nonhealing wound/ulcer'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neuropathic foot ulcers, including diabetic ulcers, most commonly occur at areas of increased pressure at sites of bony prominences, such as over the metatarsal heads. They typically are surrounded by a thick hyperkeratosis, and the ulcer often has undermined borders  (<a class="graphic graphic_picture graphicRef51991" href="/d/graphic/51991.html" rel="external">picture 14</a>). The extremity and the ulcer are usually insensitive. (See  <a class="medical medical_review" href="/d/html/1749.html" rel="external">"Evaluation of the diabetic foot"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other possible causes of ulcers include rheumatoid arthritis and other connective tissue diseases with associated vasculitis, hemoglobinopathies (eg, sickle cell disease), pyoderma gangrenosum, and tumors, especially squamous cell carcinoma and basal cell carcinoma. It may be necessary to have the ulcer biopsied in order to rule out these uncommon causes of lower extremity ulcers. (See  <a class="medical medical_review" href="/d/html/13680.html" rel="external">"Approach to the differential diagnosis of leg ulcers"</a>.)</p><p></p><p class="headingAnchor" id="H1100297668"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118466.html" rel="external">"Society guideline links: Chronic venous disorders"</a>.)</p><p class="headingAnchor" id="H23143980"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15729.html" rel="external">"Patient education: Varicose veins and other vein disease in the legs (The Basics)"</a>) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/2728.html" rel="external">"Patient education: Lower extremity chronic venous disease (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic venous disease</strong> – Chronic lower extremity venous disease is the most common vascular disorder encompassing the full spectrum of signs and symptoms as classified by the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) system (C0 to C6)  (<a class="graphic graphic_table graphicRef52388" href="/d/graphic/52388.html" rel="external">table 1</a>). Advanced levels of chronic venous disease (ie, C4 to C6) are associated with chronic disability, diminished quality of life, and high health care costs. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms</strong> – Initial clinical presentation is highly variable. The most common symptoms of chronic venous disease are lower extremity heaviness, aching, swelling, itching, discomfort, and pain. Physical findings include abnormal venous dilation (ie, telangiectasias-corona phlebectatica, reticular veins, varicose veins), edema, inflammation, dermatitis, skin changes, and ulceration. Pain associated with venous disease is typically worse at the end of the day than the beginning of the day and when standing or when seated with the feet dependent for prolonged periods of time and improves with limb elevation and walking. (See <a class="local">'Symptoms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical signs</strong> – The most common clinical sign of lower extremity chronic venous disease is abnormal venous dilation (ie, telangiectasias, reticular veins, varicose veins). The signs of advanced venous disease (CEAP 4 to 6) include lower extremity edema, skin pigmentation, dermatitis/eczema, lipodermatosclerosis, and ulceration. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>No clinical signs</strong> – Approximately 20 percent of patients with symptoms consistent with venous disease have no visible clinical signs. (See <a class="local">'No clinical signs (C0)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Telangiectasias/reticular veins</strong> – Telangiectasias are a confluence of dilated intradermal venules/capillaries less than 1 millimeter in diameter and are the most frequently encountered manifestation of venous disease. Reticular veins are dilated, bluish subdermal veins, 1 to 3 millimeters in diameter, and are usually tortuous. (See <a class="local">'Telangiectasia/reticular veins (C1)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Varicose veins</strong> – Varicose veins are subcutaneous dilated, tortuous veins greater than 3 millimeters in diameter. (See <a class="local">'Varicose veins (C2)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Edema</strong> – Lower extremity swelling is generally worse with prolonged standing and improves with leg elevation and walking. In the early stages of chronic venous insufficiency, edema may be present only at the end of the day; however, with time it can become persistent throughout the day. (See <a class="local">'Edema (C3)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Advanced venous disease</strong> – Chronic severe edema, skin changes (ie, pigmentation, dermatitis, lipodermatosclerosis), and venous ulceration are signs of advanced venous disease (ie, chronic venous insufficiency), which is associated with superficial and/or deep venous reflux and/or obstruction. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Skin pigmentation</strong> – Pigmentation associated with chronic venous insufficiency is derived from the breakdown of red blood cells that have extravasated through damaged capillaries into the dermis. (See <a class="local">'Skin pigmentation/dermatitis (C4a)'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Stasis dermatitis</strong> – Stasis dermatitis is an inflammatory process that presents as an eczematous rash. The associated pruritus can be difficult to relieve. The resulting excoriations from scratching can be a source of skin infection, and areas of skin breakdown can develop into ulcers. (See <a class="local">'Skin pigmentation/dermatitis (C4a)'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Lipodermatosclerosis</strong> – Lipodermatosclerosis is a fibrosing panniculitis of the subcutaneous tissue. Patients with lipodermatosclerosis are particularly prone to repeated bouts of cellulitis. (See <a class="local">'Lipodermatosclerosis (C4b)'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Venous ulcers</strong> – Venous ulcers are usually located low on the medial or lateral malleolus in the anatomic distribution of the refluxing saphenous veins. Venous ulcers are tender, shallow, exudative, and have a base of granulation tissue; these features usually distinguish venous ulcers from other types of ulcers that occur in the lower extremities. (See <a class="local">'Venous ulceration (C5, C6, C6r)'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Criqui MH, Jamosmos M, Fronek A, et al. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol 2003; 158:448.</a></li><li><a class="nounderline abstract_t">Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21:635.</a></li><li><a class="nounderline abstract_t">Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53:2S.</a></li><li><a class="nounderline abstract_t">Bergan JJ, Schmid-Schönbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med 2006; 355:488.</a></li><li><a class="nounderline abstract_t">Chiesa R, Marone EM, Limoni C, et al. Effect of chronic venous insufficiency on activities of daily living and quality of life: correlation of demographic factors with duplex ultrasonography findings. Angiology 2007; 58:440.</a></li><li><a class="nounderline abstract_t">Tsai S, Dubovoy A, Wainess R, et al. Severe chronic venous insufficiency: magnitude of the problem and consequences. Ann Vasc Surg 2005; 19:705.</a></li><li><a class="nounderline abstract_t">Kaplan RM, Criqui MH, Denenberg JO, et al. Quality of life in patients with chronic venous disease: San Diego population study. J Vasc Surg 2003; 37:1047.</a></li><li><a class="nounderline abstract_t">Duque MI, Yosipovitch G, Chan YH, et al. Itch, pain, and burning sensation are common symptoms in mild to moderate chronic venous insufficiency with an impact on quality of life. J Am Acad Dermatol 2005; 53:504.</a></li><li><a class="nounderline abstract_t">Langer RD, Ho E, Denenberg JO, et al. Relationships between symptoms and venous disease: the San Diego population study. Arch Intern Med 2005; 165:1420.</a></li><li><a class="nounderline abstract_t">Chiesa R, Marone EM, Limoni C, et al. Chronic venous disorders: correlation between visible signs, symptoms, and presence of functional disease. J Vasc Surg 2007; 46:322.</a></li><li><a class="nounderline abstract_t">Asbeutah AM, Asfar SK, Shawa NJ, et al. Is venous reflux a common disease in post-thrombotic patients with unilateral deep vein thrombosis episode? Phlebology 2007; 22:8.</a></li><li><a class="nounderline abstract_t">Yamaki T, Nozaki M. Patterns of venous insufficiency after an acute deep vein thrombosis. J Am Coll Surg 2005; 201:231.</a></li><li><a class="nounderline abstract_t">Labropoulos N, Waggoner T, Sammis W, et al. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg 2008; 48:407.</a></li><li><a class="nounderline abstract_t">Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009; 78:539.</a></li><li><a class="nounderline abstract_t">Scott TE, Mendez MV, LaMorte WW, et al. Are varicose veins a marker for susceptibility to coronary heart disease in men? Results from the Normative Aging Study. Ann Vasc Surg 2004; 18:459.</a></li><li><a class="nounderline abstract_t">Mäkivaara LA, Ahti TM, Luukkaala T, et al. Persons with varicose veins have a high subsequent incidence of arterial disease: a population-based study in Tampere, Finland. Angiology 2007; 58:704.</a></li><li><a class="nounderline abstract_t">Kurz X, Lamping DL, Kahn SR, et al. Do varicose veins affect quality of life? Results of an international population-based study. J Vasc Surg 2001; 34:641.</a></li><li><a class="nounderline abstract_t">Palfreyman S. Assessing the impact of venous ulceration on quality of life. Nurs Times 2008; 104:34.</a></li><li><a class="nounderline abstract_t">Hareendran A, Bradbury A, Budd J, et al. Measuring the impact of venous leg ulcers on quality of life. J Wound Care 2005; 14:53.</a></li><li><a class="nounderline abstract_t">van Korlaar I, Vossen C, Rosendaal F, et al. Quality of life in venous disease. Thromb Haemost 2003; 90:27.</a></li><li><a class="nounderline abstract_t">Almeida JI, Kaufman J, Göckeritz O, et al. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study). J Vasc Interv Radiol 2009; 20:752.</a></li><li><a class="nounderline abstract_t">Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162:1144.</a></li><li><a class="nounderline abstract_t">Renner R, Gebhardt C, Simon JC, Seikowski K. Changes in quality of life for patients with chronic venous insufficiency, present or healed leg ulcers. J Dtsch Dermatol Ges 2009; 7:953.</a></li><li><a class="nounderline abstract_t">Wrona M, Jöckel KH, Pannier F, et al. Association of Venous Disorders with Leg Symptoms: Results from the Bonn Vein Study 1. Eur J Vasc Endovasc Surg 2015; 50:360.</a></li><li><a class="nounderline abstract_t">Van der Velden SK, Shadid NH, Nelemans PJ, Sommer A. How specific are venous symptoms for diagnosis of chronic venous disease? Phlebology 2014; 29:580.</a></li><li><a class="nounderline abstract_t">Newland MR, Patel AR, Prieto L, et al. Neuropathy and gait disturbances in patients with venous disease: a pilot study. Arch Dermatol 2009; 145:485.</a></li><li><a class="nounderline abstract_t">Padberg FT Jr, Maniker AH, Carmel G, et al. Sensory impairment: a feature of chronic venous insufficiency. J Vasc Surg 1999; 30:836.</a></li><li><a class="nounderline abstract_t">Shiman MI, Pieper B, Templin TN, et al. Venous ulcers: A reappraisal analyzing the effects of neuropathy, muscle involvement, and range of motion upon gait and calf muscle function. Wound Repair Regen 2009; 17:147.</a></li><li><a class="nounderline abstract_t">Abbade LP, Lastória S, Rollo Hde A. Venous ulcer: clinical characteristics and risk factors. Int J Dermatol 2011; 50:405.</a></li><li><a class="nounderline abstract_t">Moffatt CJ, Franks PJ, Doherty DC, et al. Prevalence of leg ulceration in a London population. QJM 2004; 97:431.</a></li><li><a class="nounderline abstract_t">Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002; 46:381.</a></li><li><a class="nounderline abstract_t">O'Brien JF, Grace PA, Perry IJ, Burke PE. Prevalence and aetiology of leg ulcers in Ireland. Ir J Med Sci 2000; 169:110.</a></li><li><a class="nounderline abstract_t">Wittens C, Davies AH, Bækgaard N, et al. Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2015; 49:678.</a></li><li><a class="nounderline abstract_t">Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord 2020; 8:342.</a></li><li class="breakAll">Zenilman J, Valle MF, Malas MB, et al. Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities. Report No: 13(14)-EHC121-EF, Agency for Healthcare Research and Quality (US); Rockland, MD 2013.</li><li><a class="nounderline abstract_t">Coon WW, Willis PW 3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation 1973; 48:839.</a></li><li><a class="nounderline abstract_t">Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther 2010; 23:375.</a></li><li><a class="nounderline abstract_t">Walsh SN, Santa Cruz DJ. Lipodermatosclerosis: a clinicopathological study of 25 cases. J Am Acad Dermatol 2010; 62:1005.</a></li><li><a class="nounderline abstract_t">Uhl JF, Cornu-Thénard A, Carpentier PH, et al. Clinical and hemodynamic significance of corona phlebectatica in chronic venous disorders. J Vasc Surg 2005; 42:1163.</a></li><li><a class="nounderline abstract_t">Forssgren A, Nelzén O. Changes in the aetiological spectrum of leg ulcers after a broad-scale intervention in a defined geographical population in Sweden. Eur J Vasc Endovasc Surg 2012; 44:498.</a></li><li><a class="nounderline abstract_t">Meulendijks AM, de Vries FMC, van Dooren AA, et al. A systematic review on risk factors in developing a first-time Venous Leg Ulcer. J Eur Acad Dermatol Venereol 2019; 33:1241.</a></li><li><a class="nounderline abstract_t">Vivas A, Lev-Tov H, Kirsner RS. Venous Leg Ulcers. Ann Intern Med 2016; 165:ITC17.</a></li><li><a class="nounderline abstract_t">Mervis JS, Kirsner RS, Lev-Tov H. Protocol for a longitudinal cohort study: determination of risk factors for the development of first venous leg ulcer in people with chronic venous insufficiency, the VEINS (venous insufficiency in South Florida) cohort. BMJ Open 2019; 9:e023313.</a></li></ol></div><div id="topicVersionRevision">Topic 8198 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12936900" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Chronic venous disease in an ethnically diverse population: the San Diego Population Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7707568" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21536172" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16885552" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Chronic venous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17875957" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Effect of chronic venous insufficiency on activities of daily living and quality of life: correlation of demographic factors with duplex ultrasonography findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16034514" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Severe chronic venous insufficiency: magnitude of the problem and consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12756353" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Quality of life in patients with chronic venous disease: San Diego population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16112363" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Itch, pain, and burning sensation are common symptoms in mild to moderate chronic venous insufficiency with an impact on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15983292" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Relationships between symptoms and venous disease: the San Diego population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17600668" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Chronic venous disorders: correlation between visible signs, symptoms, and presence of functional disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18265548" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Is venous reflux a common disease in post-thrombotic patients with unilateral deep vein thrombosis episode?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16038821" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Patterns of venous insufficiency after an acute deep vein thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18515036" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19413999" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Inflammatory cytokines in vascular dysfunction and vascular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15156364" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Are varicose veins a marker for susceptibility to coronary heart disease in men? Results from the Normative Aging Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18216380" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Persons with varicose veins have a high subsequent incidence of arterial disease: a population-based study in Tampere, Finland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11668318" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Do varicose veins affect quality of life? Results of an international population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18979958" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Assessing the impact of venous ulceration on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15739651" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Measuring the impact of venous leg ulcers on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12876622" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Quality of life in venous disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19395275" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12020185" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19386020" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Changes in quality of life for patients with chronic venous insufficiency, present or healed leg ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26141786" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Association of Venous Disorders with Leg Symptoms: Results from the Bonn Vein Study 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24390751" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : How specific are venous symptoms for diagnosis of chronic venous disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19380677" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Neuropathy and gait disturbances in patients with venous disease: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10550181" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Sensory impairment: a feature of chronic venous insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19320881" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Venous ulcers: A reappraisal analyzing the effects of neuropathy, muscle involvement, and range of motion upon gait and calf muscle function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21413949" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Venous ulcer: clinical characteristics and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15208431" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Prevalence of leg ulceration in a London population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11862173" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Venous leg ulcer: incidence and prevalence in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11006665" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Prevalence and aetiology of leg ulcers in Ireland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25920631" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32113854" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The 2020 update of the CEAP classification system and reporting standards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32113854" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The 2020 update of the CEAP classification system and reporting standards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4744789" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Venous thromboembolism and other venous disease in the Tecumseh community health study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20666825" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Lipodermatosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20466175" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Lipodermatosclerosis: a clinicopathological study of 25 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16376209" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Clinical and hemodynamic significance of corona phlebectatica in chronic venous disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22925998" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Changes in the aetiological spectrum of leg ulcers after a broad-scale intervention in a defined geographical population in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30422345" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A systematic review on risk factors in developing a first-time Venous Leg Ulcer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27479227" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Venous Leg Ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30610020" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Protocol for a longitudinal cohort study: determination of risk factors for the development of first venous leg ulcer in people with chronic venous insufficiency, the VEINS (venous insufficiency in South Florida) cohort.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
